Results 241 to 250 of about 105,036 (275)

Traditional knowledge on health: balancing innovation, ethics and intellectual property. [PDF]

Bull World Health Organ
Goel S, Matsabisa M, Jiao F, Portella C, Asthana V, Ekandzi N, Saluja MS, Germann S, Souza JP.   +8 more
europepmc   +1 more source

Navigating the USPTO's AI inventorship guidance in AI-driven drug discovery. [PDF]

J Law Biosci
Wang J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Patents, Pharmaceutical Industry and Healthcare

Pharmaceutical Patent Analyst, 2023
[Abstract Not Available]
Ruqaiyyah Siddiqui, Naveed A Khan
openaire   +3 more sources

Patenting Pharmaceuticals in China

Pharmaceutical Patent Analyst, 2016
The pharmaceutical industry is developing fast in China and the market is getting more mature in recent years, which draws the attention of multinational producers and investors. Patent protection is important for the commercialization of pharmaceuticals in China.
Weiwei, Han, Juhua, Luo
openaire   +2 more sources

Replace Pharmaceutical Patents Now

PharmacoEconomics, 2007
Pharmaceutical patents are anachronistic holdovers from an era in which modern economic understanding and tax tools were unavailable. Superior mechanisms lie somewhere between a first best pricing solution for the entire economy at one extreme and the current arrangements at the other. We discuss the economics of suggested alternatives and suggest that
Earl L, Grinols, James W, Henderson
openaire   +2 more sources

Problem pharmaceutical patents

World Patent Information, 1996
Abstract These days, the number of pharmaceutical patent applications which do not specify the principal active ingredient in the form of a chemical name or structure is increasing. These patents are difficult to retrieve in retrospective on-line searches using chemical structures or keywords.
Masaharu Kubo, Yukinori Itoh
openaire   +1 more source

Gene Patents—A Pharmaceutical Perspective

Cambridge Quarterly of Healthcare Ethics, 1998
The decade-long debate over ownership of living human materials has recently intensified with the ability of biomedical research to isolate, purify, and use human genes and gene products as therapeutics, factories for the production of therapeutics, and targets for the identification of therapeutic pharmaceuticals.
openaire   +2 more sources

Patent citation analysis of Allergan pharmaceutical patents

Expert Opinion on Therapeutic Patents, 1998
This is the second in a series of articles that apply patent citation analysis techniques to pharmaceutical patents. Co-citation clustering was used to identify the core pharmaceutical technological competencies of Allergan, Inc. and the technology fronts that this company is advancing.
Mary Ellen Mogee, Richard G Kolar
openaire   +1 more source

Pharmaceutical patents and price controls

Clinical Therapeutics, 2002
Since 1995, every member-country of the World Trade Organization (WTO) has agreed to honor a 20-year patent-life, from the date of a pharmaceutical company's application for the patent, in the country of application. Patent protection retards competitive imitation of an invented product.
openaire   +2 more sources